Objective A systematic review of studies published between January 1995 and April 2010
aimed at determining the effect of combined hormonal contraceptives (CHCs), administered …

This review provides an update of knowledge regarding venous thromboembolism (VTE)
and combined hormonal contraceptives (CHCs) in the light of new progestins and new …

Since the early 1960s, it has been well documented that combined hormonal contraceptives
increase the risk of cardiovascular disease. Newer generation of oral formulations, as well …

To date, 13 studies have provided data on the risk of venous thromboembolism associated
with combined oral contraceptives containing drospirenone or the norelgestromincontaining …

Background. New studies about the influence of hormonal contraception on the risk of
venous thromboembolism (VTE) have been published. Aim. To evaluate new …

Introduction Currently available combined oral contraceptives (COC) reportedly increase the
risk of venous thromboembolism (VTE). We aimed to quantify this risk considering both …

Abstract In October 1995 the Committee on Safety of Medicines advised UK doctors and
pharmacists that oral contraceptives containing desogestrel and gestodene were associated …

Hormonal contraceptives are a popular method of contraception, but their use has been
associated with an increased risk for venous thromboembolism. In order to reduce such risk …

Objective To provide a comprehensive overview of the risk of venous thrombosis in women
using different combined oral contraceptives. Design Systematic review and network meta …

While venous thromboembolism (VTE) is rare in young women of reproductive age,
combined oral contraceptives increase the risk of VTE. In the patient in whom combined …